The dyskeratotic changes in the lesions of hyperkeratosis lenticularis perstans were examined electron microscopically and histochemically. Under electron microscopy, the formation of keratohyalin granules was reduced and there was a lack of lamellar granule formation. In addition, the catabolic processes were disturbed, and ribosomal and mitochondrial structures remained, and lipid crystal-like structures were seen in the stratum corneum. The structure of the desmosomes of the stratum corneum was identical to that seen in the stratum spinosum. Staining with thiol-specific, fluorescent reagent, N-(7-dimethylamino-4-methyl-coumarinyl) maleimide (DACM) demonstrated strong fluorescence in the cytoplasm of the stratum corneum and granulosum without reduction by 2-mercaptoethanol. With reduction, moderate fluorescence was only seen at the periphery of the stratum corneum cells. These results indicate that there is a cystine-rich protein in the stratum corneum cells.

Keywords:
Hyperkeratosis lenticularis perstans, Cystine-rich protein, Stratum corneum, Abnormal catabolic process
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.